Suppr超能文献

硝苯地平和维拉帕米可抑制健康志愿者乙状结肠对进食的肌电反应。

Nifedipine and verapamil inhibit the sigmoid colon myoelectric response to eating in healthy volunteers.

作者信息

Bassotti G, Calcara C, Annese V, Fiorella S, Roselli P, Morelli A

机构信息

Department of Clinical Medicine, University of Perugia Medical School, Italy.

出版信息

Dis Colon Rectum. 1998 Mar;41(3):377-80. doi: 10.1007/BF02237495.

Abstract

BACKGROUND

Constipation is not an infrequent side effect complained of by patients taking calcium channel blockers. This effect may reduce patients' compliance and yield potentially serious consequences. However, the underlying mechanisms for constipation caused by such compounds are not known.

AIMS

The purpose of the present study was to assess the effects of nifedipine and verapamil on the sigmoid myoelectric response to eating, a physiologic test of colonic motor function.

SUBJECTS AND METHODS

Nine healthy male volunteers with no previous abdominal surgery were recruited for the study and underwent three paired studies at two-week intervals. Myoelectric sigmoid activity was recorded by means of two clip electrodes introduced within the viscus without preparation for 30 minutes basally and 90 minutes postprandially. Each study was preceded by placebo, nifedipine (20 mg), or verapamil (120 mg).

RESULTS

Analysis of the tracings revealed that nifedipine strongly inhibited the sigmoid myoelectric response to the meal. This response was also significantly reduced in those taking verapamil compared with the placebo group, although to a much lesser extent than in those taking nifedipine.

CONCLUSIONS

We conclude that constipation as a result of some calcium channel blockers may be caused by inhibition of colonic motor activity by nifedipine and, to a lesser extent, by verapamil. The latter compound probably displays other mechanisms (reduced colonic transit, increased water absorption) also responsible for this side effect.

摘要

背景

便秘是服用钙通道阻滞剂的患者常抱怨的一种副作用。这种效应可能会降低患者的依从性并产生潜在的严重后果。然而,此类化合物导致便秘的潜在机制尚不清楚。

目的

本研究的目的是评估硝苯地平和维拉帕米对乙状结肠进食肌电反应的影响,这是一种结肠运动功能的生理测试。

受试者和方法

招募了9名无腹部手术史的健康男性志愿者进行该研究,并每隔两周进行三项配对研究。通过在未作准备的情况下经内脏插入的两个夹式电极记录乙状结肠肌电活动,基础状态下记录30分钟,餐后记录90分钟。每项研究前分别给予安慰剂、硝苯地平(20毫克)或维拉帕米(120毫克)。

结果

对记录的分析显示,硝苯地平强烈抑制乙状结肠对进食的肌电反应。与安慰剂组相比,服用维拉帕米的患者该反应也显著降低,尽管程度远小于服用硝苯地平的患者。

结论

我们得出结论,某些钙通道阻滞剂导致的便秘可能是由硝苯地平抑制结肠运动活动引起的,维拉帕米在较小程度上也有此作用。后一种化合物可能还表现出其他机制(结肠转运减慢、水吸收增加)也导致了这种副作用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验